Thema: US9553061055
West Pharmaceutical, US9553061055
West Pharmaceutical (ISIN US9523901012) stellt in sterilen Reinräumen Vials und Elastomer-Verschlüsse für Injektionssysteme her - Foto: THN
West Pharmaceutical stock gets higher 2026 outlook after Q3 growth
West Pharmaceutical stock gets a higher full-year outlook after a strong third quarter. Management also lowered its capital-spending forecast.
ad-hoc-news.de, vor 59 Minuten
West Pharmaceutical, US9553061055
West Pharmaceutical stock: 2026 outlook rises after Q3 growth ...
West Pharmaceutical stock gained a stronger outlook after improved third-quarter results. Revenue and adjusted earnings guidance both moved higher.
ad-hoc-news.de, 03.11.26 13:47 Uhr
West Pharmaceutical, US9553061055
West raises 2026 outlook for West Pharmaceutical stock
Third-quarter revenue reached USD 874.5 million, up 8.7 percent year over year. West Pharmaceutical stock costs EUR 380.05 on October 29, 2026.
ad-hoc-news.de, 29.10.26 13:22 Uhr
West Pharmaceutical, US9553061055
West Pharmaceutical signs USD 200 million loan before West ...
West signs a USD 200 million loan on October 26, 2026. West Pharmaceutical stock costs EUR 354.95 on October 27 before October 29 results.
ad-hoc-news.de, 27.10.26 13:50 Uhr
West Pharmaceutical, US9553061055
West Pharmaceutical raises dividend to USD 0.26 per share ...
West Pharmaceutical lifts its quarterly dividend 18 percent to USD 0.26 per share. Payment for West Pharmaceutical stock is due November 18 2026 to holders of record November ...
ad-hoc-news.de, 25.10.26 14:14 Uhr
West Pharmaceutical, US9553061055
TD Cowen raises West Pharmaceutical stock target from USD ...
West Pharmaceutical stock heads to October 29 results with USD 872.30 million Q2 revenue. Full-year adjusted EPS guidance is USD 8.85-9.05.
ad-hoc-news.de, 18.10.26 12:39 Uhr
West Pharmaceutical, US9553061055
Barclays raises West Pharmaceutical target to USD 440 for ...
West Pharmaceutical stock costs EUR 324.85 on October 8, 2026 versus EUR 327.35. Second-quarter 2026 revenue rose 13.80 percent to USD 872.30 million.
ad-hoc-news.de, 08.10.26 11:57 Uhr
West Pharmaceutical, US9553061055
West Pharmaceutical stock gains 2.09 percent on CPHI plans ...
West Pharmaceutical stock is backed by Q2 2026 revenue of USD 872.3 million up 13.8 percent year over year. Management raised full-year adjusted EPS guidance to USD 8.85-9.05. ...
ad-hoc-news.de, 05.10.26 17:51 Uhr
West Pharmaceutical, US9553061055
Morgan Stanley raises target for West Pharmaceutical stock ...
West Pharmaceutical stock costs EUR 325.50 on October 5, 2026 versus EUR 324.35, plus 0.35 percent. Revenue in the second quarter was USD 872.30 million, up 13.8 percent.
ad-hoc-news.de, 05.10.26 09:53 Uhr
West Pharmaceutical, US9553061055
West Pharmaceutical Services stock reports strong Q2 growth ...
